Rare disease therapy Crysvita to be barred from NHS
admin 15th June 2018 Uncategorised 0Children and young people with X-linked hypophosphataemia (XLH) are unlikely to get routine access to Kyowa Kirin’s Crysvita on the NHS.
More: Rare disease therapy Crysvita to be barred from NHS
Source: News